SALSA MLPA Probemix P420 MPN mix 1 detects mutations frequently found in myeloproliferative neoplasms in the JAK2, MPL, CALR and KIT genes.
Contents: 25 MLPA probes, including probes for JAK2 c.1849G>T (p.V617F), JAK2 c.1627_1632delGAAGAT (p.E543_D544del), JAK2 c.1624_1629delAATGAA (p.N542_E543del), MPL c.1544G>T (p.W515L), MPL c.1543_1544TG>AA (p.W515K), KIT c.2447A>T (p.D816V), CALR c.1092_1143del52 (p.L367fs*46), and CALR c.1154_1155insTTGTC (p.K385fs*47).
Tissue: human genomic DNA.
Application: research on myeloproliferative neoplasms (MPNs), including polycythemia vera (PV), essential thrombocythemia (ET), primary myelofibrosis (PMF), and systemic mastocytosis (SM).
For research use only (RUO). Not for use in diagnostics.
P420 MPN mix 1 requires an allelic burden of at least 10–20% to detect the targeted mutations. To detect allelic burdens as low as 1%, see P520 MPN mix 2.
The SALSA MLPA Probemix P420 MPN mix 1 is a research use only (RUO) assay for detection of eight different mutations frequently found in MPNs in the JAK2, MPL, CALR and KIT genes.
MPNs are clonal hematopoietic stem cell malignancies, characterized by excessive production of blood cells. MPNs are subdivided in polycytemia vera (PV), essential thrombocytemia (ET), primary myelofibrosis (PMF) and less common conditions like chronic neutrophilic leukemia (CNL), chronic eosinophilic leukemia (CEL), hypereosinophilic syndrome (HES) and systemic mastocytosis (SM).
Discovery of a frequent JAK2 mutation (9p24.1), common to classic MPNs (PV, ET and PMF), has linked these diseases on a molecular level. The current WHO diagnostic criteria for classic MPNs include presence of JAK2, CALR or MPL mutations. The JAK2 V617F point mutation is detected in ~98% of PV patients, and in ~60% of patients with ET and PMF, whereas other JAK2 exon 12 mutations are commonly found in V617F-negative PV patients. P420-B1 MPN mix 1 probemix contains three mutation-specific JAK2 probes: one probe for V617F and two probes for the most common exon 12 mutations N542_E543del and E543_D544del.
Mutations in the MPL gene (1p34.2) are found in 4-11% of JAK2 V617F negative ET and PMF patients. This problemix contains two mutation-specific probes for MPL, W515K and W515L, that are diagnostically relevant in PV, ET and PMF according to the WHO classification.
The discovery of novel CALR gene (19p13.13) mutations in ET and PMF provides additional diagnostic tools for MPNs. Patients with ET and PMF but negative for JAK2 and MPL mutations, have been reported to harbour somatic insertions and deletions in exon 9 of the CALR gene. A 52-bp deletion (type 1) and a 5-bp insertion (type 2) are the most common mutations found in the CALR gene (53% and 32%, respectively). These mutations result in a frameshift to an alternative reading frame (Klampfl et al. 2013, Nangalia et al. 2013). CALR mutation-specific probes for the 52-bp deletion (L367fs*46, type 1) and 5-bp insertion (K385fs*47, type 2) are included in this probemix.
In addition, a probe specific for the D816V mutation in the KIT gene (4q12) is present. This is the most common KIT mutation and is present in >90% of patients with SM. Consequently, the presence of this mutation is considered a diagnostic criterion of SM according to the WHO classification.
SALSA MLPA Probemix P420 MPN mix 1 is for research use only (RUO) in all territories.
SALSA Binning DNA SD069 is an artificial DNA sample with a signal for all probes in the P420 MPN mix 1 probemix. Inclusion of a reaction with SD069 in initial experiments and in experiments following a change in electrophoresis conditions is recommended to aid in the creation of a bin set that links peaks to the probes that produce them. Binning DNA cannot be used as a reference sample in the MLPA data analysis, and cannot be used to quantify the signals of mutation-specific probes.
A vial of SALSA Binning DNA SD069 is included with every order of the P420 MPN mix 1 probemix, but it is possible to order additional vials separately.
For more information, see the product description.
A general SALSA MLPA Reagent Kit is required for MLPA experiments (to be ordered separately).
A vial is included with every order of this probemix, but additional vials can also be purchased separately.
The prices above are list prices for direct orders from MRC Holland. Contact us for a quote that takes discounts and additional costs (such as shipping costs) into account. Different prices apply for orders through one of our sales partners; contact your local supplier for a quote.
Inclusion of a positive sample is usually not required, but can be useful for the analysis of your experiments. MRC Holland has very limited access to positive samples and cannot supply such samples. We recommend using positive samples from your own collection. Alternatively, you can use positive samples from an online biorepository, such as the Coriell Institute.
See this support article for commercially available positive samples that can be used with this product.